Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Australasian Journal of Neuroscience
Volume 31 (2021): Issue 1 (May 2021)
Open Access
The Effect of Bevacizumab on Vestibular Schwannoma Related to Neurofibromatosis Type 2
Simone Ardern-Holmes
Simone Ardern-Holmes
,
Cassandra White
Cassandra White
,
Sarita Bahure
Sarita Bahure
,
Simon So
Simon So
,
Geoff McCowage
Geoff McCowage
,
Elizabeth Hovey
Elizabeth Hovey
,
Simon Troon
Simon Troon
,
Paul De Souza
Paul De Souza
,
John Simes
John Simes
,
Michael Slancar
Michael Slancar
,
Mark Dexter
Mark Dexter
and
Mark Wong
Mark Wong
| May 01, 2021
Australasian Journal of Neuroscience
Volume 31 (2021): Issue 1 (May 2021)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
research-article
Published Online:
May 01, 2021
Page range:
5 - 14
DOI:
https://doi.org/10.21307/ajon-2021-002
Keywords
Bevacizumab
,
Vestibular Schwannoma
,
Neurofibromatosis Type 2
,
3-D Volumetric Analysis
,
Audiometry
© 2021 Simone Ardern-Holmes et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.